| Financial Year |
March 31 2023 |
| Monetary Funds |
64,334,651.49 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
150,000.00 |
| Accounts Receivable |
229,732,189.39 |
| Advances to Suppliers |
60,516,303.78 |
| Other Receivables |
52,525,460.25 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
203,788,375.58 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
56,874,973.76 |
| Total Current Assets |
740,167,088.44 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
286,688,437.89 |
| Investment Properties |
-- |
| Fixed Assetes |
73,429,651.85 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
74,283,114.52 |
| R&D expenses |
1,824,380.41 |
| Goodwill |
692,278.33 |
| Long-Term Deferred and Prepaid Expenses |
3,753,332.90 |
| Deferred Income Tax Assets |
37,623,924.51 |
| Other Non-Current Assets |
45,494,390.03 |
| Sub-Total of Non-Current Assets |
541,773,724.05 |
| Total Assets |
1,281,940,812.49 |
| Short-Term Loans |
90,022,693.06 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
307,259,946.37 |
| Accounts Received In Advance |
4,960.00 |
| Employee Compensation Payable |
96,152,061.49 |
| Taxes Payable |
14,038,978.94 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
29,892,464.12 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
9,464,041.16 |
| Other Current Liabilities |
27,315,893.00 |
| Sub-Total of Current Liabilities |
904,821,183.79 |
| Long-term Loans |
5,005,597.22 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,402,407.78 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
15,951,782.30 |
| Total Liabilities |
920,772,966.09 |
| Paid-In Capital(Or Share Stock) |
430,000,000.00 |
| Capital Surplus |
115,389,147.94 |
| Surplus Reserve |
26,927,422.86 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-285,320,433.48 |
| Minority Stockholder's Interest |
85,590,377.34 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
275,577,469.06 |
| Owner's Equity（Stockholder's Equity） |
361,167,846.40 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,281,940,812.49 |
